US lawmakers questions FDAs drug inspection programme in India and China
Tuesday, 25 June 2024 Three US lawmakers have raised concerns about the FDA's foreign drug inspection program in India and China, citing inconsistent inspection outcomes. They noted significant variability in findings, suggesting potential issues in inspector competency and thoroughness, and called for further investigation into the program's efficacy and reliability.
Donald Trump: Mass layoffs have rocked the U.S. Health and Human Services Department (HHS) as up to 10,000 employees face termination under a sweeping restructuring plan ordered by Donald Trump. The move follows an executive order stripping collective bargaining rights from federal health agencies, sparking outrage among Democratic lawmakers and unions. Key agencies affected include the FDA, CDC, NIH, and CMS, with major cuts in healthcare oversight, medical research, and public health funding. Critics warn of a devastating impact on disease prevention, pandemic response, and federal healthcare programs. Is this a move for efficiency, or a dangerous power play?
#Trump #HealthDepartment #MassLayoffs #HHS #DonaldTrump #USPolitics #JobCuts #HealthcareCrisis #PublicHealth #UnionRights #TrumpExecutiveOrder #CDC #FDA #NIH #Medicare #Medicaid #OneIndia